This topic contains a solution. Click here to go to the answer

Author Question: A patient is having difficulty achieving adequate anticoagulation with prescribed doses of warfarin. ... (Read 89 times)

NguyenJ

  • Hero Member
  • *****
  • Posts: 516
A patient is having difficulty achieving adequate anticoagulation with prescribed doses of warfarin. The nurse realizes that what might be indicated for this patient?
 
  1. genetic testing to determine if the patient metabolizes warfarin slower
  2. use of a different anticoagulant
  3. review of the patient's diet
  4. analysis of the patient's lifestyle

Question 2

Through genetic testing, a patient learns that he has an apolipoprotein E2 gene. What should this information suggest to the nurse?
 
  1. The patient is at reduced risk for developing Alzheimer disease.
  2. The patient is at increased risk for developing Alzheimer disease.
  3. The patient is at risk for contracting malaria.
  4. The patient is at risk for developing colorectal cancer.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

abctaiwan

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

Correct Answer: 1

One use of genetic testing involves predicting or studying the patient's response to particular medications. Pharmacogenetic testing has shown that 20 of Caucasians metabolize warfarin more slowly and take longer to achieve therapeutic dosing. Genetic testing could help determine why the patient has not achieved successful anticoagulation. There might not be another anticoagulant available for the patient. Reviewing the patient's diet might provide some information regarding dietary reasons for the unsuccessful anticoagulation of the patient. An analysis of the patient's lifestyle will not help determine why the patient has not been achieved successful anticoagulation.

Answer to Question 2

Correct Answer: 1

The apolipoprotein E gene provides instructions to make a protein that combines with fats in the body to form molecules called lipoproteins which are responsible for packaging cholesterol and other fats and carrying them through the bloodstream. Research has shown that a person who inherits at least one E4 allele will have a greater chance of developing Alzheimer disease. Inheriting the E2 allele does not indicate that a person is more likely to develop Alzheimer disease. The apolipoprotein E gene is not a predictor for contracting malaria or developing colorectal cancer.





 

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library